Advanced Therapy Medicinal Products

Shaping the Future of ATMP Therapies

Advanced Therapy Medicinal Products (ATMPs), also known as cell and gene therapy, offer patients hope for a brighter tomorrow and are revolutionizing the treatment of cancers, neurological disorders and genetic disorders.

GBA was an early partner in the ATMP therapy space with multiple projects leveraging modular facility design (pods) and advanced manufacturing equipment.  The team has helped ATMP clients with feasibility studies, renovations, new construction and full-service delivery as well as assisting the movement of their life-saving treatments through the full development cycle starting from the non-clinical process development through clinical trials and into commercial production.

Researching, developing and bringing ATMP therapies and vectors to market poses many challenges, and GBA is ready to use its experience to design, construct and validate clients’ ATMP processes and facilities.